Age acceleration differences in controls and subjects with the

$ 20.99

4.7
(550)
In stock
Description

Download scientific diagram | Age acceleration differences in controls and subjects with the ESRD. (a) DNAmAgeHannum 39 ; (b) DNAmAge 40 ; (c) IEAA 15,16 ; (d) EEAA 15,16 ; (e) DNAmPhenoAge 38 ; (f) DNAmGrimAge 41 . from publication: Accelerated epigenetic aging and inflammatory/immunological profile (ipAGE) in patients with chronic kidney disease | Chronic kidney disease (CKD) is defined by reduced estimated glomerular filtration rate (eGFR). This failure can be related to a phenotype of accelerated aging. In this work we considered 76 subjects with end-stage renal disease (ESRD) and 83 healthy controls. We evaluated | Chronic Kidney Disease, Epigenetics and Epigenomics | ResearchGate, the professional network for scientists.

THE EFFECT OF MULTIDOMAIN INTERVENTIONS ON GLOBAL COGNITION, SYMPTOMS OF DEPRESSION AND APATHY – A POOLED ANALYSIS OF TWO RANDOMIZED CONTROLLED TRIALS • The Journal of Prevention of Alzheimer's Disease

Accelerated epigenetic aging and inflammatory/immunological profile (ipAGE) in patients with chronic kidney disease

Schizophrenia is characterized by age- and sex-specific effects on epigenetic aging

Aging as an unintended consequence

Age acceleration differences in controls and subjects with the ESRD.

Evidence of accelerated epigenetic aging in patients diagnosed with coronary artery disease: Results of the LipidCardio study

Frontiers Interactions Between Different Age-Related Factors Affecting Balance Control in Walking

Deterministically Setting Hunting Speed Restrictions - Railway Age

A Guide to Buying Kid's Electric Car by Kids Ride On Cars - Issuu

Frontiers Interactions Between Different Age-Related Factors Affecting Balance Control in Walking

Effects of age and thyroid status on speed of performance of individual

Speed Tweaks

Mikhail KRIVONOSOV, Junior researcher, Master of Applied Mathematics and Informatics, Nizhny Novgorod State University, Nizhniy Novgorod, Department of Neurotechnology